For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Status epilepticus – adults and children: Definition and timeline, Consider the cause at the same time, Step 1 – benzodiazepines (adults), Step 2 – after two benzodiazepine doses (adults), Step 3 – refractory status: anaesthesia, Children (beyond the neonatal period) – concise for emergency, anaesthesia and intensive care teams, with sources and medically reviewed.
What the chapter covers
- Definition and timeline
- Consider the cause at the same time
- Step 1 – benzodiazepines (adults)
- Step 2 – after two benzodiazepine doses (adults)
- Step 3 – refractory status: anaesthesia
- Children (beyond the neonatal period)
Complete in the app
Weight-based doses in mg and ml, tables, algorithms and calculators – also offline, on phone, tablet and PC. Try full access free for 7 days.
Sources and guidelines
- Rosenow F, Weber J et al. S2k-Leitlinie Status epilepticus im Erwachsenenalter. Deutsche Gesellschaft für Neurologie gemeinsam mit der Österreichischen Gesellschaft für Neurologie (ÖGN), 2020; AWMF-Register 030-079, korrigierte Registerfassung 03/2022, gültig bis 29.06.2025.
- Trollmann R, Brandl U et al. (Gesellschaft für Neuropädiatrie). S1-Leitlinie Therapie des konvulsiven Status epilepticus im Kindes- und Jugendalter (jenseits der Neugeborenenperiode). AWMF-Register 022-019 (Fassung 2025; Recherche nennt auch Stand 01/2026.
- Resuscitation Council UK. Paediatric advanced life support algorithm.
- Djakow J, Turner NM, Skellett S et al. European Resuscitation Council Guidelines 2025 Paediatric Life Support. Resuscitation 2025;215 Suppl 1:110767.
- Jünemann et al. Prähospitale Behandlung von Anfallsclustern und Status epilepticus. Clin Epileptol 2025.
- Trinka E, Cock H, Hesdorffer D et al. A definition and classification of status epilepticus.
- Glauser T, Shinnar S, Gloss D et al. Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults. Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr 2016;16:48–61.
- Kapur J, Elm J, Chamberlain JM et al. Randomized trial of three anticonvulsant medications for status epilepticus (ESETT). N Engl J Med 2019;381:2103–2113.
- Silbergleit R, Durkalski V, Lowenstein D et al. Intramuscular versus intravenous therapy for prehospital status epilepticus (RAMPART). N Engl J Med 2012;366:591–600.
- National Institute for Health and Care Excellence (NICE). Epilepsies in children, young people and adults. NICE guideline NG217, 2022 (mit späteren Aktualisierungen)
- Neurocritical Care Society. Emergency Neurological Life Support (ENLS), Version 5.0.
- Lyttle MD et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE)
- Dalziel SR et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT)
- Summaries of product characteristics of authorised products – product and section for each dose in the app.